AtlantiCare has entered a clinical partnership with Global Neurosciences Institute to take its nationally recognized, comprehensive neurosciences services to the next level of care. GNI brings to the partnership experts who will enhance AtlantiCare’s already robust services. This will include providing a comprehensive array of treatments and therapies, from a complete range of neurosurgical services supporting AtlantiCare’s Joint Commission Comprehensive Stroke Center designation combined with innovative functional neurosurgical procedures to neurology services treating diseases including Alzheimer’s Disease/Cognitive Disorders, Parkinson’s Disease/Movement Disorders, Epilepsy, Multiple Sclerosis and more.
At the Vision 2030 announcement event, AtlantiCare President and CEO Michael J. Charlton stated, “VISION 2030 puts AtlantiCare in the driver’s seat of a new journey that upends the current paradigms prevalent in healthcare by investing in new technologies, accelerating transformation and ending disparities in care. Yes, our goals are ambitious. But they are achievable because our team members are fully invested in the mission and the communities we serve.”
Dr. Erol Veznedaroglu, MD, stated, “Our goal has always been to ensure that all patients have access to the best, most innovative care and treatment available. We are committed to eliminating barriers between narrowly focused medical specialties to enable holistic, collaborative, patient-centered care and are excited to work with AtlantiCare to make that vision a reality.”